Details

Service: Geographic Markets, Asia Markets, China
Industry: Pharmaceuticals
Type: Business and industry issue
Date: 6/10/2011

China's pharmaceutical industry – Poised for the giant leap

Over the next few decades China has the potential to become one of the leaders of the pharmaceutical world. With every big company in the sector focusing on this region as a source of growth, the country is likely to play an increasingly significant role in the way drugs are invented, tested and perhaps even regulated.

Download Now

China's pharmaceutical industry – Poised for the giant leap [PDF 2.59MB]

PDF files require Adobe Reader to view

Download Adobe Reader

Key insights

China's booming economy and high GDP growth make its pharmaceutical market the fifth largest and one of the most attractive in the world
China's 12th Five-Year Plan focuses on achieving growth through continuous reform and reporting incentives from high-end research to affordable drug pricing
The world's top 20 multinational medicine makers have extensive operations in the country, including R&D facilities, joint ventures and wholly owned companies
Consolidating the pharmaceutical distribution sector and biotechnology are the focus areas for the next five years
A combination of traditional and next-generation advantages is turning China into a haven for outsourcing by pharmaceutical companies.

Contact us

Contact KPMG to find out more about our services or industry experience.

Pharmaceuticals

KPMG’s Pharmaceutical industry practice advises clients with critical business and key industry issues.

Australia-China corridor

The long-term demographic and social forces shaping China and its 12th Five-Year plan will greatly impact Australia's prosperity for decades to come.

Australia China Business Practice

Our Australia China Business Practice assists Chinese companies investing in Australia and supports Australian companies investing in China.

Subscribe to related feeds

© 2013 KPMG, an Australian partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative ("KPMG International"), a Swiss entity. All rights reserved.

KPMG International Cooperative ("KPMG International") is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.